Navigation Links
Research Volunteer Registry from Verified Clinical Trials Adopted by ICON
Date:12/17/2012

Garden City, New York (PRWEB) December 17, 2012

Verified Clinical Trials today announced that ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, is using its research volunteer registry in its Clinical Pharmacology units in the US to ensure volunteer safety and clinical data quality.

The Verified Clinical Trials online registry, currently available in the US and Canada, prevents multiple trial enrollment and premature re-enrollment into another study by a research subject. The clinical research database volunteer registry safeguards data integrity and patient safety without delaying the screening process by ensuring that only qualified research subjects are enrolled in a study.

Dr. Mitchell D. Efros, CEO of Verified Clinical Trials, stated "ICON is one of the world's largest and most prominent leaders in the clinical trial business and their adoption of the Verified Clinical Trials registry significantly strengthens our network. By utilizing Verified Clinical Trials, ICON has further demonstrated its commitment to providing high quality clinical research data. Verified Clinical Trials continues to partner with many of the world's largest CROs and pharmaceutical companies in the world."

“Simultaneous study enrollment places the health of the volunteer at risk and may compromise the integrity of clinical data,” commented Mario Rocci, President, ICON Development Solutions. “The Verified Clinical Trials volunteer clinical research database registry allows us to maintain our high standards of data quality and patient safety and improves our ability to enroll qualified research subjects in a timely manner.”

ICON will use the Verified Clinical Trials volunteer registry in its Clinical Pharmacology units located in San Antonio, Texas and Omaha, Nebraska.

About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, RSVP or visit verifiedclinicaltrials.com.

Media Contacts
Verified Clinical Trials
Kerri Weingard, Chief Operating Officer, Verified Clinical Trials
Tel: +1 516 998-7499
KWeingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/2012/12/prweb10240744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017 The Global Implantable ... CAGR of around 7.5% over the next decade ... of the prominent trends that the market is ... diseases & graft transplant surgeries and medical implants ... market is categorized into immunomodulatory biomaterials, natural, polymers, ...
(Date:1/17/2017)... --  Pulmatrix, Inc . (NASDAQ: PULM ), ... to address serious pulmonary diseases, today announced that its ... of CF patients, PUR1900, has been designated as a ... & Drug Administration. Under the QIDP ... of novel drugs against important pathogens, Pulmatrix will receive ...
(Date:1/17/2017)... N.Y. , Jan. 17, 2017  Northwell ... speed the advance of precision cancer research. ... largest health care provider, Northwell Health ... year. Indivumed, GmbH is a Germany ... anti-cancer medical therapies. Together they will greatly expand ...
(Date:1/17/2017)... Shanghai and Hong Kong (PRWEB) , ... January ... ... innovation lifecycle management software, and NetDimensions, a global provider of learning and performance ... reseller agreement for the mainland China market. , “In the life sciences industry, ...
Breaking Biology Technology:
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , the ... of its patent portfolio, which grew to over 40 granted and pending ... , , ... filed patent entitled " System, Device, and Method Estimating Force ... enables device makers to forego costly hardware components needed to estimate the ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium ... announced the appointment of new CEO James ... executive with decades of experience, has served in ... Cisco, where he specialized in expanding a pipeline ... technology portfolios. He most recently served as managing ...
Breaking Biology News(10 mins):